DsRNA for biological control of lasioderma serricorne
Through the dsRNA composition targeting LsATPsyn-β, the RNA interference technology is used to solve the problems of tobacco A-resistant to chemical agents and environmental pollution, achieving efficient and safe tobacco A-control, which is suitable for large-scale applications.
Patent Information
- Application Number
- CN202411178581.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-26
- Publication Date
- 2024-12-06
AI Technical Summary
Among the existing tobacco A control methods, fumigation of chemical agents leads to drug resistance, environmental pollution and food safety risks, and a safe and environmentally friendly non-chemical control method is urgently needed.
DsRNA and compositions targeting LsATPsyn-β are developed, and dsRNA sprays or compositions are prepared by targeting the ATP synthetase β subunit gene of tobacco aphrodisiac by using RNA interference technology to prepare for prevention and treatment of tobacco aphrodisiac.
It has achieved high mortality rate, high safety and environmentally friendly tobacco argent prevention and control, and is convenient for large-scale application through feeding, with high practicality and prospects.
Smart Images

Figure CN119082109A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of pest control, and relates to a dsRNA targeting LsATPsyn-β and a composition comprising the dsRNA. The invention also relates to the application of the dsRNA and the composition comprising the dsRNA for controlling tobacco beetles. Background Art
[0002] Tobacco beetles [Lasioderma serricorne (Fabricius)], belonging to the Anobiidae family of the order Coleoptera, are a worldwide tobacco storage pest, and records of this pest date back more than 3,000 years. Tobacco beetles are omnivorous stored product pests with a wide range of hosts. They can seriously harm stored tobacco and its products, stored grains and processed products, and are a worldwide storage pest. Tobacco beetles mainly eat through their larvae hiding in the host, which seriously affects the yield and quality of stored products. The damage caused by tobacco beetles is highly concealed. According to estimates by the United States Department of Agriculture, insect pests have caused up to 1% of tobacco losses worldwide. Among them, tobacco beetles are the most harmful, causing much greater quality losses than other stored tobacco pests. Tobacco beetles are widely found in tobacco leaves, tobacco stems and various cigarette products of flue-cured tobacco, burley tobacco and oriental tobacco. They not only eat tobacco leaves, causing holes on the surface of the leaves, causing them to break, be incomplete, and be perforated, which leads to a decrease in the yield and silk rate of tobacco leaves. In severe cases, the leaves are completely eaten, leaving only the veins, which seriously affects the availability of tobacco leaves. In addition, they excrete a large amount of feces, produce odors, leave insect corpses, pollute tobacco leaves and tobacco products, and greatly reduce the quality of cigarettes. The problems caused by them, such as oily cigarettes and insect cigarettes, are of great concern to consumers, easily lead to consumer complaints, affect business reputation, and cause immeasurable indirect losses to the tobacco industry.
[0003] The harm of tobacco beetles accompanies almost every stage of tobacco product production. Its prevention and control methods are diverse, and the main methods include clean control, physical control, biological control and chemical control. Control research mainly focuses on plant extracts and essential oils, Bt toxins, radiation, gas conditioning, temperature control and other methods. Because chemical control is simple and easy, it is still the main means for the tobacco industry at home and abroad to control tobacco beetles and other stored tobacco pests. The prevention and control of tobacco beetles in my country is mainly based on chemical fumigation, and the most commonly used fumigants are methyl bromide and phosphine. Methyl bromide fumigation was once the main technical means for the prevention and control of tobacco beetles, but it has been banned due to its destructive effect on the atmospheric ozone layer. At present, most of the world's stored tobacco pests are controlled by phosphine (PH3) fumigation. However, due to the long-term irrational use of phosphine, pests have developed serious resistance to it, and in some cases, fumigation control may even fail. The phenomenon of tobacco beetles developing resistance to PH3 was first reported in 1994, and at the same time, the first case of phosphine fumigation failure occurred in India. Zettler et al. studied its resistance to pesticides and found that half of the tobacco beetles in tobacco warehouses in North Carolina, USA, had varying degrees of resistance to phosphine, and some showed high resistance. At the same time, many disadvantages of chemical control, such as residual pesticides and environmental pollution, have also attracted people's attention, posing hidden dangers to food safety and human safety. With the emergence of the concepts of green tobacco products and organic tobacco products in recent years, the control of harmful substances in all links of tobacco product production will become increasingly strict, and the method of fumigating tobacco leaves with chemical agents to prevent and control tobacco beetles will face unprecedented challenges. Therefore, the tobacco industry urgently needs to seek safer, environmentally compatible, and non-chemical methods of tobacco beetle control.
[0004] RNAi (RNA interference) is RNA interference. It regulates gene expression through RNA after transcription and introduces double-stranded RNA (dsRNA) molecules into eukaryotic cells, resulting in specific gene silencing (gene silencing) of genes with sequence homology. When double-stranded RNA appears in eukaryotic cells, the endonuclease Dicer in the cytoplasm cuts it into small RNA fragments (siRNA) with a length of 21-23bp. Under the action of RNA helicase, the siRNA double strands are unwound to form a sense strand and an antisense strand. The antisense strand that appears at this moment then combines with endonucleases, exonucleases and helicases to form an RNA-induced silencing complex (RISC) with nuclease function. RISC specifically binds to the homologous region in mRNA and cuts mRNA at both ends that complementarily bind to the antisense strand of siRNA. Once mRNA is cut, it is immediately degraded. In this way, dsRNA triggers the cell's degradation response to its homologous target gene RNA. If a pest is fed or injected with specific dsRNA, the dsRNA can be absorbed by the pest's intestines and then cut into small siRNAs by nucleases in the pest's cells, which can interfere with the normal function of the pest's genes with the same sequence, thereby killing the pest. Because RNAi is highly efficient and specific, dsRNA is considered a very specific "pesticide."
[0005] Monsanto's RNAi-based BioDirect TM The technology has shown considerable prospects in the field of pest control. The technology uses important target genes related to growth and development in plant diseases and insect pests as targets to synthesize and prepare specific dsRNA sprays for pest control in agricultural production. Early tests showed that insecticides made using BioDirect technology are very effective in controlling Colorado flower beetles, while beneficial insects such as ladybugs are not affected. Mitter et al. prepared BioClay spray by tightly combining the dsRNA molecules of the CMV-2b gene with clay nanoparticles LDH, which allows RNAi to remain on the plant leaves for up to 20 days, thereby completing the silencing of the CMV-2b gene and achieving the purpose of resisting CMV virus. This technology can also be applied to the field of insect-resistant production.
[0006] Regarding the use of dsRNA for biological control of tobacco beetles, the invention patent CN107586785A discloses the use of dsRNA of chitin deacetylase gene of tobacco beetles in the control of tobacco beetles, but the mortality rate of young larvae is only about 76% 15 days after injection of dsRNA, and the dsRNA needs to be delivered to the tobacco beetle through microinjection, which is difficult to apply in production. Therefore, it is urgent to develop dsRNA with high mortality rate against tobacco beetles and easy to use. Summary of the invention
[0007] After extensive research, the present inventors have discovered a dsRNA targeting LsATPsyn-β, and thus provided a composition and method for controlling tobacco beetles.
[0008] dsRNA
[0009] In one aspect, the present invention provides a dsRNA comprising a sense strand and an antisense strand, wherein the sense strand comprises a nucleotide sequence as shown in SEQ ID NO:1.
[0010] In some embodiments, the dsRNA targets the LsATPsyn-β gene.
[0011] In some embodiments, the antisense strand is at least partially complementary to the sense strand.
[0012] The at least partially complementary means that the two sequences can be completely complementary, or generally no more than 6, 5, 4, 3, 2 or 1 mismatched base pairings, while retaining the ability to hybridize under relevant conditions. Those skilled in the art can determine the conditions that are most suitable for testing the complementarity of the two sequences based on the final application of the hybridized nucleotides. Such conditions can be stringent conditions, such as 400mM NaCl, 40mM PIPES pH 6.4, 1mM EDTA, 50°C or 70°C for 12-16 hours, followed by washing. Other conditions, such as physiologically relevant conditions that may be encountered in vivo, can also be applied.
[0013] In some embodiments, the sense strand has no more than 6 nucleotide bases mismatch with the antisense strand. In some embodiments, the sense strand has no more than 5 nucleotide bases mismatch with the antisense strand. In some embodiments, the sense strand has no more than 4 nucleotide bases mismatch with the antisense strand. In some embodiments, the sense strand has no more than 3 nucleotide bases mismatch with the antisense strand. In some embodiments, the sense strand has no more than 2 nucleotide bases mismatch with the antisense strand. In some embodiments, the sense strand has no more than 1 nucleotide base mismatch with the antisense strand. In some embodiments, the sense strand is fully complementary to the antisense strand.
[0014] In some embodiments, the antisense strand comprises a nucleotide sequence having at least 80% (eg, at least 85%, at least 90%, at least 95%, at least 99%) complementarity to the nucleotide sequence shown in SEQ ID NO:1.
[0015] In some embodiments, the antisense strand comprises the complement of the nucleotide sequence shown in SEQ ID NO:1.
[0016] In some embodiments, the dsRNA comprises nucleotides that are each independently selected from natural nucleotides or modified nucleotides.
[0017] mixture
[0018] In another aspect, the present invention provides a mixture comprising siRNA produced by endonuclease cleavage of the dsRNA of the present invention.
[0019] In some embodiments, the siRNA comprises a sense strand and an antisense strand, and the sense strand comprises at least 14 consecutive nucleotides starting from any position among nucleotides 1-439 in the nucleotide sequence shown in SEQ ID NO:1.
[0020] In some embodiments, the endonuclease is a Dicer endonuclease.
[0021] In some embodiments, the cleavage is performed in vitro.
[0022] Composition
[0023] In another aspect, the present invention provides a composition comprising the dsRNA or mixture described herein, and one or more adjuvants.
[0024] In some embodiments, the adjuvant includes a carrier and / or an adjuvant.
[0025] In some embodiments, the carrier is selected from water, a solvent, or a filler.
[0026] In some embodiments, the carrier is a sugar solution.
[0027] In some embodiments, the auxiliary agent is selected from one or more of the following: emulsifier, dispersant, wetting agent, dispersion medium, penetrant, antifreeze agent, thickener, stabilizer, disintegrant, defoamer, antimicrobial agent, antioxidant, anti-redeposition agent, bleaching agent, colorant, enzyme, fat, fluorescent substance, fungicide, hydrotrope, humectant, optical brightener, fragrance carrier, fragrance, preservative, protein, silicone, soil release agent, solubilizer, sugar derivative, etc.
[0028] In some embodiments, the composition further comprises one or more components selected from the group consisting of pesticides, insect attractants, herbicides, and plant growth regulators.
[0029] In some embodiments, the composition is solid, liquid, or semisolid.
[0030] In some embodiments, the composition can be formulated into any one dosage form selected from the following: suspension, solution, powder, granule, injection (including injection solution, sterile powder for injection and concentrated solution for injection), and spray.
[0031] Preparation method
[0032] The dsRNA described in the present invention can be prepared by any method known in the art, such as in vitro transcription, solid phase synthesis and liquid phase synthesis, among which solid phase synthesis and liquid phase synthesis both have commercial customized services.
[0033] On the other hand, the present invention also provides a method for preparing the dsRNA of the present invention, comprising:
[0034] (1) providing total RNA of Nicotiana tabacum and reversely transcribing it to obtain cDNA of Nicotiana tabacum;
[0035] (2) using the tobacco beta cDNA obtained in (1) as a template, and performing PCR amplification using primers whose sequences are shown in SEQ ID NOs: 2-5;
[0036] (3) using the amplified product obtained in (2) as a template for in vitro transcription to obtain the sense strand and antisense strand of the dsRNA;
[0037] (4) Annealing the sense strand and the antisense strand to obtain the dsRNA.
[0038] In some embodiments, in step (2), PCR amplification is performed using primers whose sequences are shown in SEQ ID NOs: 2 and 5, respectively, to obtain the positive strand transcription template of the dsRNA; PCR amplification is performed using primers whose sequences are shown in SEQ ID NOs: 3 and 4, respectively, to obtain the antisense strand transcription template of the dsRNA; in step (3), the positive strand and the antisense strand are obtained by in vitro transcription from the positive strand transcription template and the antisense strand transcription template, respectively.
[0039] In some embodiments, step (3) comprises using T7 RNA polymerase.
[0040] In some embodiments, step (1) comprises extracting total RNA of the tobacco beetle.
[0041] application
[0042] On the other hand, the present invention also provides the use of the dsRNA, mixture or composition of the present invention for controlling tobacco beetles. In some embodiments, the dsRNA or composition is used alone or in combination with another attractant or insecticide.
[0043] On the other hand, the present invention also provides a method for controlling tobacco beetles, comprising: contacting the dsRNA, mixture or composition of the present invention with plants infested by tobacco beetles or their products or tobacco beetles.
[0044] In some embodiments, the contacting comprises applying (eg, spraying, soaking, feeding) the dsRNA, mixture or composition of the present invention to the surface of the plant or its product or to the tobacco beetle.
[0045] In some embodiments, the plant or its product is selected from tobacco or its product, grain or its product. In some embodiments, the plant or its product is selected from tobacco leaves, tobacco stems and cigarette products of flue-cured tobacco, burley tobacco and / or oriental tobacco.
[0046] In some embodiments, the dsRNA or composition is used alone or in combination with another attractant or insecticide.
[0047] On the other hand, the present invention also provides a kit comprising primers whose sequences are shown as SEQ ID NOs: 2-5 respectively.
[0048] In some embodiments, the kit is used to prepare the dsRNA of the invention.
[0049] In some embodiments, the kit prepares the sense strand of the dsRNA of the present invention by using primers whose sequences are shown in SEQ ID NO: 2 and 5, respectively.
[0050] In some embodiments, the kit prepares the antisense strand of the dsRNA of the present invention by using primers whose sequences are shown in SEQ ID NO: 3 and 4, respectively.
[0051] Definition of terms
[0052] In the present invention, unless otherwise specified, the scientific and technical terms used herein have the meanings commonly understood by those skilled in the art. Meanwhile, in order to better understand the present invention, the definitions and explanations of the relevant terms are provided below.
[0053] When the terms "for example," "such as," "including," "comprising," or variations thereof are used herein, these terms will not be considered as limiting terms, but will be interpreted to mean "but not limited to" or "not limited to."
[0054] The terms "a" and "an" and "the" and similar referents in the context of describing the invention (especially in the context of the following claims) should be construed to cover both the singular and the plural, unless otherwise indicated herein or clearly contradicted by context.
[0055] In this article, unless otherwise specified, capital letters C, G, U, A, T represent the base composition of nucleotides, including modified and unmodified nucleotides. The term "modified nucleotide" refers to a nucleotide independently having a modified ribose moiety, a modified internucleoside bond or a modified base, covering substitution, addition or removal (e.g., using a functional group or atom) of an internucleoside bond, a ribose moiety or a base.
[0056] As used herein, the term "LsATPsyn-β" refers to the β subunit of tobacco ATP synthase. ATP synthase is an enzyme that catalyzes ATP synthesis in cells. Its structure includes two functional units, F1 and F0, of which the β subunit is an important component of F1 and contains the catalytic sites required for ATP synthesis and hydrolysis.
[0057] As used herein, the term "dsRNA" refers to double-stranded ribonucleotides. They are mainly derived from: (1) mRNA produced in cells, under the action of RNA polymerase, synthesizes a double-stranded RNA (dsRNA) from a single-stranded RNA as a template; (2) RNA in cells produces a stem-loop structure, which is cut by nuclease to form dsRNA; (3) in vitro synthesis. After dsRNA is cut by Dicer nuclease in cells, it forms multiple small RNA fragments with specific lengths and structures, namely siRNA, which further triggers the RNAi phenomenon.
[0058] As used herein, the term "siRNA" means an RNA molecule that can induce RNAi phenomenon with sequence specificity, is composed of a sense strand and an antisense strand, and has a partially or completely complementary double-stranded structure. The length of the complementary double-stranded structure can be 14 to 30 base pairs, such as 14, 15, 16, 17, 18, 19, 20 or 21 base pairs, such as 14 to 19 base pairs.
[0059] As used herein, unless otherwise specified, the term "complementary" refers to the ability of an oligonucleotide of a first sequence to hybridize with an oligonucleotide of a second sequence under certain conditions and form a double-stranded structure. "At least partially complementary" means that the two sequences can be completely complementary, or generally no more than 6, 5, 4, 3 or 2 or 1 mismatched base pairings, while retaining the ability to hybridize under relevant conditions. In addition, when two oligonucleotides are designed to form one or more single-stranded overhangs during hybridization, such overhangs should not be considered as mismatches in terms of determining complementarity. In this article, when meeting the above hybridization ability requirements, "complementary" sequences can also include non-Watson (Watson) -Crick (Crick) base pairs and / or base pairs formed from non-natural and modified nucleotides. Such non-Watson (Watson) -Crick (Crick) base pairs include but are not limited to G: U wobble base pairing or Hoogstein (Hu Gesten) base pairing. Correspondingly, in this article, unless otherwise specified, "mismatch" means that in a duplex molecule, the bases at corresponding positions are not paired in a complementary form.
[0060] Those skilled in the art will be able to determine the conditions most suitable for testing the complementarity of two sequences based on the ultimate application of the hybridized nucleotides. Such conditions may, for example, be stringent conditions, such as 400 mM NaCl, 40 mM PIPES pH 6.4, 1 mM EDTA, 50° C. or 70° C. for 12-16 hours, followed by washing. Other conditions, such as physiologically relevant conditions that may be encountered in vivo, may also be applied.
[0061] Advantageous Effects of the Invention
[0062] The present invention provides a dsRNA molecule targeting the LsATPsyn-β gene of tobacco beetles and its use in preventing and controlling tobacco beetles. The method for preventing and controlling tobacco beetles using the dsRNA molecule of the present invention has a high tobacco beetle mortality rate, high safety, and good environmental compatibility. At the same time, the dsRNA molecule of the present invention can prevent and control tobacco beetles by feeding, is convenient for large-scale application, has high practicality, and has good application prospects. BRIEF DESCRIPTION OF THE DRAWINGS
[0063] Figure 1:Lethality of tobacco beetles after microinjection of LsATPsyn-β dsRNA. Among them, CK represents injection of ddH2O, dsGFP represents injection of GFP dsRNA, and dsLsATPsyn-β represents injection of LsATPsyn-β dsRNA.
[0064] Figure 2 :Phenotype of tobacco beetles fed with LsATPsyn-β dsRNA.
[0065] Figure 3 :The mortality rate of tobacco beetles after feeding with LsATPsyn-β dsRNA. Among them, CK represents feeding with 0.5% sucrose solution + 3% food coloring, dsGFP represents feeding with 0.5% sucrose solution + 3% food coloring + 2μg / μl GFP dsRNA, and dsLsATPsyn-β represents feeding with 0.5% sucrose solution + 3% food coloring + 2μg / μl LsATPsyn-β dsRNA.
[0066] Sequence information
[0067] Table 1: The information of the sequences involved in the present invention is described in the table below:
[0068] DETAILED DESCRIPTION
[0069] The invention is now described in the following non-limiting examples.
[0070] Those skilled in the art will appreciate that the embodiments describe the present invention by way of example and are not intended to limit the scope of protection claimed in the present application. The experimental methods in the embodiments are conventional methods unless otherwise specified. If specific conditions are not specified in the embodiments, they are carried out according to conventional conditions or conditions recommended by the manufacturer. If the manufacturer of the reagents or instruments used is not specified, they are all conventional products that can be obtained commercially.
[0071] Example 1: Acquisition of LsATPsyn-β dsRNA
[0072] Experimental animals: Nicotiana tabacum, collected from the tobacco storage laboratory of Zhengzhou Tobacco Research Institute of China National Tobacco Corporation and raised in an artificial incubator. Feed: 70% oatmeal + 30% whole wheat flour; Feeding conditions: temperature 28±2℃, relative humidity 70%±5%, dark control.
[0073] 1.1 Extraction and reverse transcription of total RNA from tobacco beta
[0074] After collecting and mixing larval samples, the mixed sample RNA was extracted using the GeneAnswer Animal Tissue / Cell RNA Extraction Kit. The concentration and purity of RNA were tested by NanoDrop 2000, and the quality and integrity of total RNA were tested by 1.0% agarose gel electrophoresis. The qualified total RNA was used for the synthesis of the first strand of cDNA, and reverse transcription was performed using the Roche First Strand cDNA Synthesis Kit Transcriptor First Strand cDNA Synthesis Kit.
[0075] 1.2 Cloning of LsATPsyn-β gene
[0076] Combined with the previous screening of key growth and development-related genes of tobacco beetles, the tobacco beetle ATP synthase β subunit gene LsATPsyn-β was selected as the target gene. This gene is involved in the energy synthesis and metabolism of tobacco beetles and is an ideal target gene for dsRNA biological control of tobacco beetles.
[0077] Using cDNA as a template, PCR amplification was performed using primers (LsATPsyn-βF / R, see Table 2). After the PCR amplification product was recovered from the gel, connected to the PMD18-T vector, and transformed into Escherichia coli DH5α. After single clone positive verification, it was sent to BGI for sequencing verification.
[0078] 1.3LsATPsyn-βdsRNA in vitro synthesis
[0079] The potential target sequence sites of siRNA in the target gene were predicted in siRNA target finder (http: / / www.genscript.com / siRNA_target_finder.html), and the target site sequences were BLAST-matched in GenBank, and the continuous 17bp high homology sequences were eliminated to ensure specificity. The intervals without potential target sites in the human genome were selected as the dsRNA target fragments, and the fragment length was controlled at about 300bp. The plasmids sequenced correctly during the target gene cloning process were used as templates, and primers were designed with reference to the Promega T7 RiboMAX Express RNAi System (Table 2), and GFP was used as a control. After the positive and antisense ssRNAs of the target sequence were transcribed and synthesized respectively with reference to the T7 RiboMAX Express RNAi System, they were mixed and annealed into dsRNA, and then purified after nuclease digestion to remove DNA and ssRNA to obtain a large number of dsRNAs of the target gene target fragments. The dsRNA of the target gene LsATPsyn-β (its positive chain sequence is SEQ ID NO: 1) was successfully obtained, and the concentration was measured after purification and recovery for use.
[0080] Table 2: dsRNA synthesis primers
[0081]
[0082] Example 2: Determination of the lethality of LsATPsyn-β dsRNA against tobacco beetles
[0083] 2.1 Determination of the lethality of LsATPsyn-β dsRNA microinjection into tobacco beetles
[0084] Forty larvae of the 3rd and 4th instar tobacco beetles were collected, 10 in a group, and four groups were repeated. The insect samples to be injected were collected in a test tube and anesthetized with CO2 for about 30 seconds. Then, the tobacco beetle larvae were neatly placed in the grooves of the offset plate made of agarose using a fine brush. Using a cell microdissection injection system (Eppendorf, FemotoJet + TransferMan NK2), 0.20 μl of LsATPsyn-β dsRNA (1 μg / μl) was injected into the tobacco beetle larvae. ddH2O was used as a blank control, and GFP dsRNA was used as a negative control. After the injection, the animals were transferred to a feed of 70% oatmeal + 30% whole wheat flour for continued feeding, and the mortality rate was observed and statistically analyzed after 5, 10 and 15 days. Figure 1 As shown, the lethality of LsATPsyn-β dsRNA was 37.5% 5 days after injection, 55% 10 days after injection, and 92.5% 15 days after injection.
[0085] 2.2 Determination of the mortality rate of tobacco beetles fed with LsATPsyn-β dsRNA
[0086] The synthesized candidate target gene LsATPsyn-β dsRNA was used to feed tobacco beetle larvae. 40 3rd-4th instar larvae of tobacco beetles were collected, 10 in each group, and four replicates were set up. Treatment group: larvae were fed with 0.5% sucrose solution + 3% food coloring + 2μg / μl LsATPsyn-β dsRNA; blank group: larvae were fed with 0.5% sucrose solution + 3% food coloring; negative control group: larvae were fed with 0.5% sucrose solution + 3% food coloring + 2μg / μl GFP dsRNA. After feeding tobacco beetle larvae with sucrose drops for 12 hours, the larvae with observable midgut staining were selected and transferred to 70% oatmeal powder + 30% whole wheat flour feed for continued feeding, and fed once every 3 days. Figure 2 and Figure 3 As shown, after feeding LsATPsyn-β dsRNA for 15 days, the mortality rate of tobacco beetles reached 87.5%, which can effectively play a preventive and control role.
[0087] Although the specific embodiments of the present invention have been described in detail, it will be understood by those skilled in the art that various modifications and changes may be made to the details according to all the teachings that have been published, and these changes are within the scope of protection of the present invention. The full scope of the present invention is given by the attached claims and any equivalents thereof.
Claims
1. A dsRNA comprising a sense strand and an antisense strand, wherein: The positive strand comprises the nucleotide sequence shown in SEQ ID NO:
1.
2. The dsRNA according to claim 1, wherein The antisense strand is at least partially complementary to the sense strand; Preferably, the antisense strand comprises a nucleotide sequence having at least 80% complementarity to the nucleotide sequence shown in SEQ ID NO:
1.
3. The dsRNA according to claim 1 or 2, wherein The antisense strand comprises a complementary sequence to the nucleotide sequence shown in SEQ ID NO:
1.
4. The dsRNA of any one of claims 1 to 3, wherein the nucleotides it comprises are each independently selected from natural nucleotides or modified nucleotides.
5. A mixture comprising siRNA produced by endonuclease cleavage of the dsRNA according to any one of claims 1 to 4; Preferably, the endonuclease is Dicer endonuclease; Preferably, said cleavage is performed in vitro.
6. A composition comprising the dsRNA of any one of claims 1 to 4 or the mixture of claim 5, and one or more adjuvants; Preferably, the auxiliary agent comprises a carrier and / or an auxiliary agent; Preferably, the composition further comprises one or more components selected from the group consisting of pesticides, insect attractants, herbicides and plant growth regulators; Preferably, the composition is solid, liquid or semisolid; Preferably, the composition can be formulated into any dosage form selected from the following: suspension, solution, powder, granule, injection (including injection solution, sterile powder for injection and concentrated solution for injection), spray.
7. A method for preparing the dsRNA according to any one of claims 1 to 4, comprising: (1) providing total RNA of Nicotiana tabacum and reversely transcribing it to obtain cDNA of Nicotiana tabacum; (2) using the tobacco beta cDNA obtained in (1) as a template, and performing PCR amplification using primers whose sequences are shown in SEQ ID NOs: 2-5; (3) using the amplified product obtained in (2) as a template for in vitro transcription to obtain the sense strand and antisense strand of the dsRNA; (4) Annealing the sense strand and the antisense strand to obtain the dsRNA.
8. Use of the dsRNA according to any one of claims 1 to 4, the mixture according to claim 5 or the composition according to claim 6 for controlling tobacco beetles; Preferably, the dsRNA or composition is used alone or in combination with another attractant or insecticide.
9. A method for preventing and controlling tobacco beetles, comprising: contacting the dsRNA of any one of claims 1 to 4, the mixture of claim 5, or the composition of claim 6 with a plant infested with tobacco beetles or a product thereof or a tobacco beetle; Preferably, the contacting comprises applying (e.g., spraying, soaking, feeding) the dsRNA according to any one of claims 1 to 4, the mixture according to claim 5, or the composition according to claim 6 to the surface of the plant or its product or the tobacco beetle; Preferably, the plant or its product is selected from tobacco or its product, cereal or its product; Preferably, the plant or its product is selected from tobacco leaves, tobacco stems and cigarette products of flue-cured tobacco, burley tobacco and / or oriental tobacco.
10. A kit comprising primers having sequences as shown in SEQ ID NOs: 2-5 respectively; Preferably, the kit is used to prepare the dsRNA according to any one of claims 1 to 4.
Citation Information
Patent Citations
Lasioderma serricorne chitin deacetylase gene 1 and application of dsRNA thereof in pest control
CN107586785A
